Similar reduction in metastatic tumor burden was found with MerTK inhibition in the spontaneous liver metastasis model (Fig. 4n,o), whereas primary tumors remained unaffected (Extended Data Fig. 4p). The gene discussed is MERTK; the disease is metastatic neoplasm.